Form 483

Arrowhead DE LLC Form 483, 2026-06-17

FDA issued a Form 483 to Arrowhead DE LLC on 2026-06-17 with 5 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health5 observations

Arrowhead DE LLC · Peachtree City, United States · Issued June 17, 2026

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jun 2026
ISO 13485:2016 Clause 7.4.1

Supplier performance not monitored

Cited by Melanie W Pishnery

17 Jun 2026
ISO 13485:2016 Clause 7.5.6

Process for production and service provision not validated

Cited by Melanie W Pishnery

17 Jun 2026
ISO 13485:2016 Clause 8.2.5

Suitable methods for monitoring and measuring QMS processes not applied

Cited by Melanie W Pishnery

17 Jun 2026
ISO 13485:2016 Clause 8.2.6

Product release and delivery proceeded prior to planned agreements completed

Cited by Melanie W Pishnery

17 Jun 2026
ISO 13485:2016 Clause 8.3.4

Rework not performed according to documented procedures

Cited by Melanie W Pishnery

Inspected site

ADArrowhead DE LLCPeachtree City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
ISO 13485:2016 Clause 7.4.1Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 7.5.6Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.2.5Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.2.6Cited across public-safe Form 483 observations1x
ISO 13485:2016 Clause 8.3.4Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere